Back to search
FDAFDA · Food and drugs·Recall number D-371-2014

Quick Thin (citrus aurantium extract, sweet potato fiber, cyamopsis gum powder, alfalfa, mulberry leaf, guarana, spirulina) capsules, 400 mg, 30-count bottle, Distributed by: Bethel, Inc., Tel: (212) 568-5330.

Published December 25, 2013 · Recall initiated: August 5, 2013

Summary

FDA records drug Class I recall D-371-2014, published December 25, 2013 and initiated August 5, 2013. Recalling firm: Bethel Nutritional Consulting, Inc; Status: Terminated; Reported quantity: 9,121 bottles; Lot: Lot 10032011, Exp 10/14. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine, N-Desmethylsibutramine and phenolphthalein. Sibutramine and phenolphthalein were previously available drug products but were removed from the U.S. market making these products unapproved new drugs.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Bethel Nutritional Consulting, Inc
Distributor
Nationwide, Puerto Rico, and internet sales
Lot
Lot 10032011, Exp 10/14
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Quick Thin (citrus aurantium extract, sweet potato fiber, cyamopsis gum powder, alfalfa, mulberry leaf, guarana, spirulina) capsules, 400 mg, 30-count bottle, Distributed by: Bethel, Inc., Tel: (212) 568-5330. recalled?

Yes. FDA published recall D-371-2014 on December 25, 2013. Reported hazard: Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine, N-Desmethylsibutramine and phenolphthalein. Sibutramine and phenolphthalein were previously available drug products but were removed from the U.S. market making these products unapproved new drugs.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release